Market LIVE
Published markets; coverage varies by country
Product profile · United States

AKEEGA

 ·  Patent Litigation & Settlement History ↓

IngredientABIRATERONE ACETATE; NIRAPARIB TOSYLATE
Application typeNDA
Application216793
Product002
Dosage formTABLET
RouteORAL
Strength500MG;EQ 100MG BASE
Approval date2023-08-11
Marketing statusPrescription
Status event—
ApplicantJANSSEN BIOTECH
Product source

Current GenericRadar decision

Year2031
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2031-03-27
Patent anchor2031-03-27
Exclusivity anchor2026-08-11
Protection date2043-09-30
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2031. Anchor type: PATENT. Patent anchor: 2031-03-27. Exclusivity anchor: 2026-08-11. Anchor date: 2031-03-27. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
80715792027-08-12U U-2830NNU
English description not available.
———
80715792027-08-12U U-4368NNU
English description not available.
———
80715792027-08-12ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
81432412027-08-12U U-4368NNU
English description not available.
———
81432412027-08-12U U-2830NNU
English description not available.
———
81432412027-08-12ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
84361852029-04-24DS/DP —NNDP
English description not available.
———
84361852029-04-24ORANGE_BOOK —NNDP
English description not available.
———
80716232031-03-27DS/DP —YNTRUE_DS
English description not available.
———
80716232031-03-27ORANGE_BOOK —YNTRUE_DS
English description not available.
———
88595622031-08-04U U-4368NNU
English description not available.
———
88595622031-08-04U U-2830NNU
English description not available.
———
88595622031-08-04ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
112073112037-07-28U U-2830NNU
English description not available.
———
112073112037-07-28U U-4368NNU
English description not available.
———
112073112037-07-28ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
119864682037-07-28U U-4368NNU
English description not available.
———
119864682037-07-28U U-2830NNU
English description not available.
———
119864682037-07-28ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
119864692037-07-28U U-2830NNU
English description not available.
———
119864692037-07-28U U-4368NNU
English description not available.
———
119864692037-07-28ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
119864702037-07-28U U-4368NNU
English description not available.
———
119864702037-07-28ORANGE_BOOK U-4368NNU
English description not available.
———
119924862037-07-28U U-4368NNU
English description not available.
———
119924862037-07-28U U-2830NNU
English description not available.
———
119924862037-07-28ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
123835432037-07-28U U-2830NNU
English description not available.
———
123835432037-07-28U U-4368NNU
English description not available.
———
123835432037-07-28ORANGE_BOOK U-2830;U-4368NNU
English description not available.
———
110914592038-03-27DS/DP —NNDP
English description not available.
———
110914592038-03-27ORANGE_BOOK —NNDP
English description not available.
———
116738772038-03-27DS/DP/U U-2830NNDP
English description not available.
———
116738772038-03-27DS/DP/U U-4368NNDP
English description not available.
———
116738772038-03-27ORANGE_BOOK U-2830;U-4368NNDP
English description not available.
———
US127341802043-09-30ORANGE_BOOK U-4608;U-4609NNU
English description not available.
———
US127341802043-09-30U U-4608———
OB official listing only. TRUE_DS/DS-equivalent/claim scope/PTE-PED effective anchor remains unconfirmed.
———
US127341802043-09-30U U-4609———
OB official listing only. TRUE_DS/DS-equivalent/claim scope/PTE-PED effective anchor remains unconfirmed.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NP2023-08-112026-08-11English description not available.YY2026-08-11—Source
NP2023-08-112026-08-11English description not available.YY2026-08-11
NP
Full coverage date: 2026-08-11
Source
I-9802025-12-122028-12-12English description not available.NN——Source
I-9802025-12-122028-12-12English description not available.NN—
NP
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (17)
TypeDateRoleBasisSource
PATENT2027-08-12HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-08-12HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2029-04-24HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2031-03-27CANONICAL_ANCHOREnglish description not available.Source
PATENT2031-08-04FTO_TAILEnglish description not available.Source
PATENT2037-07-28FTO_TAILEnglish description not available.Source
PATENT2037-07-28FTO_TAILEnglish description not available.Source
PATENT2037-07-28FTO_TAILEnglish description not available.Source
PATENT2037-07-28FTO_TAILEnglish description not available.Source
PATENT2037-07-28FTO_TAILEnglish description not available.Source
PATENT2037-07-28FTO_TAILEnglish description not available.Source
PATENT2038-03-27FTO_TAILEnglish description not available.Source
PATENT2038-03-27FTO_TAILEnglish description not available.Source
PATENT2043-09-30FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2031-03-27CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.